In this article, Dr. Matulonis discusses the state of immunotherapy today, the benefits of combination therapy, immune checkpoint inhibitors and immunotherapy clinical trials.
To read more about this, follow this link.
Friday, February 8, 2019
Dana Farber: Ovarian Cancer and Immunotherapy
In this article, Dr. Matulonis discusses the state of immunotherapy today, the benefits of combination therapy, immune checkpoint inhibitors and immunotherapy clinical trials.
To read more about this, follow this link.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment